Treatment of cutaneous candidiasis in infancy and childhood with nystatin and amphotericin B.
D000666:Amphotericin B; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D000935:Antifungal Agents / Q000627:therapeutic use*; D002177:Candidiasis; D002179:Candidiasis, Cutaneous; D002648:Child; D005659:Fungicides, Industrial; D006801:Humans; D007223:Infant; D009761:Nystatin; D012871:Skin Diseases
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D000935:Antifungal Agents; D005659:Fungicides, Industrial; D009761:Nystatin; D000666:Amphotericin B
ANTIBIOTICS/therapeutic use; FUNGICIDES/therapeutic use; MONILIASIS/in infant and child; SKIN DISEASES/in infant and child